Distributing Temperature-Sensitive Pharmaceuticals Is A Risky Business

By Brian Kohr, President and CEO, CSafe Global

It is evident when reviewing the Good Distribution Practice guidelines that there has been a shift in emphasis towards Risk Management in the distribution of temperature-sensitive pharmaceuticals. Whether it’s the publication of the recent EU guidance, the revisions from USP or the PDA’s technical report 58, there can be no mistaking one thing - shippers and manufacturers are ultimately responsible for examining their supply chains using a ‘risk-based’ approach.